**Core Concept**
The patient's symptoms, including nausea, vomiting, tingling, numbness, and cyanosis of the finger, suggest a vasoconstrictive effect of the medication used to treat the acute migraine attack. This is likely due to the drug's action on serotonin receptors, leading to the constriction of peripheral blood vessels.

**Why the Correct Answer is Right**
The patient's symptoms are characteristic of ergotism, a condition caused by the vasoconstrictive effects of ergot alkaloids. These compounds act on serotonin receptors, particularly the 5-HT2A and 5-HT1D receptors, to cause vasoconstriction. The constriction of blood vessels can lead to reduced blood flow to the affected area, resulting in tingling, numbness, and cyanosis.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not specifically relate to the vasoconstrictive effects of ergot alkaloids or serotonin receptors.
* **Option B:** This option is incorrect because it does not match the clinical presentation of ergotism, which is characterized by vasoconstriction and subsequent ischemia of the affected area.
* **Option C:** This option is incorrect because it does not accurately describe the mechanism of action of the drug implicated in the patient's symptoms.

**Clinical Pearl / High-Yield Fact**
Ergot alkaloids are potent vasoconstrictors that can cause ergotism, a condition characterized by reduced blood flow to the affected area, leading to tingling, numbness, and cyanosis. This is an important consideration when using medications that contain ergot alkaloids, such as ergotamine, in the treatment of acute migraine attacks.

**Correct Answer:** D.